Invalid Symbol

Stock Research for AGGX

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


AGGX Stock Chart & Research Data

The AGGX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGGX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AGGX Due diligence Resources & Stock Charts

The AGGX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AGGX Detailed Price Forecast - CNN Money CNN View AGGX Detailed Summary - Google Finance
Yahoo View AGGX Detailed Summary - Yahoo! Finance Zacks View AGGX Stock Research & Analysis -

Stock Analysis

TradeIdeas View AGGX Trends & Analysis - Trade-Ideas Barrons View AGGX Major Holders - Barrons
NASDAQ View AGGX Call Transcripts - NASDAQ Seeking View AGGX Breaking News & Analysis - Seeking Alpha
Spotlight View AGGX Annual Report - OTC Report View AGGX OTC Short Report -
TradeKing View AGGX Fundamentals - TradeKing Charts View AGGX SEC Filings - Bar Chart
WSJ View Historical Prices for AGGX - The WSJ Morningstar View Performance/Total Return for AGGX - Morningstar
MarketWatch View the Analyst Estimates for AGGX - MarketWatch CNBC View the Earnings History for AGGX - CNBC
StockMarketWatch View the AGGX Earnings - StockMarketWatch MacroAxis View AGGX Buy or Sell Recommendations - MacroAxis
Bullish View the AGGX Bullish Patterns - American Bulls Short Pains View AGGX Short Pain Metrics -

Social Media Mentions

StockTwits View AGGX Stock Mentions - StockTwits PennyStocks View AGGX Stock Mentions - PennyStockTweets
Twitter View AGGX Stock Mentions - Twitter Invest Hub View AGGX Investment Forum News - Investor Hub
Yahoo View AGGX Stock Mentions - Yahoo! Message Board Seeking Alpha View AGGX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AGGX - Insider Cow View Insider Transactions for AGGX - Insider Cow
CNBC View AGGX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AGGX - OTC Markets
Yahoo View Insider Transactions for AGGX - Yahoo! Finance NASDAQ View Institutional Holdings for AGGX - NASDAQ

Stock Charts

FinViz View AGGX Stock Insight & Charts - StockCharts View AGGX Investment Charts -
BarChart View AGGX Stock Overview & Charts - BarChart Trading View View AGGX User Generated Charts - Trading View

Latest Financial News for AGGX

Michael Aronstein to Head AngioGenex, Inc. Board of Directors
Posted on Tuesday December 05, 2017

NEW YORK, NY / ACCESSWIRE / December 5, 2017 / AngioGenex, Inc. (OTC PINK: AGGX) announced today that Mr. Michael Aronstein, veteran financier and the President/Chief Investment Officer and Portfolio Manager ...

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Angiogenex Inc (AGGX) Watching the MFI Levels Intensely
Jonesboro Recorder - 10 hours ago
The Money Flow Indicator for Angiogenex Inc (AGGX) has touched above 60 and has found a place on investor's radar as it potentially nears the key 70 mark.

Angiogenex Inc (AGGX) RMI Charging Higher Near-Term
Danvers Record - Feb 17, 2018
Shares of Angiogenex Inc (AGGX) have seen the Relative Momentum Indicator (RMI) climb higher over the past 5 sessions. When this occurs, traders will be watching closely to see if the price breaks through a key level into overbought territory.

BeyondSpring Finds A Vascular-Disrupting Niche
Seeking Alpha - Mar 21, 2017
Against the odds, the vascular-disrupting strategy refuses to die. Last week saw the stock market debut of BeyondSpring Pharmaceuticals (NASDAQ:BYSI), a biotech whose lead asset, plinabulin, targets this tried and failed anticancer mechanism.

Angiogenex Inc Names Richard Salvador As Chairman
Reuters Key Development - Jan 7, 2008

Enter a stock symbol to view the stock details.